![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 9, 6943-6948, March 1, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Institut für Klinische und Molekulare Virologie, D-91054 Erlangen, Germany
Received for publication, September 17, 2001, and in revised form, November 13, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Herpesviral DNA packaging is a complex process
resulting in unit-length genomes packed into preformed procapsids. This
process is believed to be mediated by two packaging proteins, the
terminase subunits. In the case of double-stranded DNA
bacteriophages, the translocation of DNA was shown to be an
energy-dependent process associated with an ATPase activity
of the large terminase subunit. In the case of human cytomegalovirus it
was not known which protein has the ability to hydrolyze ATP. In this
study we expressed human cytomegalovirus terminase subunits, pUL89 and
the carboxyl-terminal half of pUL56, as GST fusion proteins and
purified these by affinity chromatography. ATPase assays demonstrated
that the enzymatic activity is exclusively associated with pUL56. The
characterization of the ATP hydrolysis showed that the enzymatic
reaction is a fast process, whereas the spontaneous ATP decay followed
slow kinetics. Interestingly, although pUL89 did not show any ATPase activity, it was capable of enhancing the UL56-associated ATP hydrolysis. Furthermore, a specific association of in vitro
translated pUL89 with the carboxyl-terminal half of GST-UL56C was
detected. This interaction was confirmed by co-immunoprecipitations of
infected cells. Our results clearly demonstrated that (i) both
terminase subunits interact with each other and (ii) the subunit pUL56
has an ATPase activity.
Human cytomegalovirus
(HCMV)1 DNA replication
results in the formation of large head-to-tail DNA concatemers. The
subsequent maturation into unit-length molecules involves site-specific
cleavage at sequence motifs (pac motifs) located within the
a sequence of the terminal and internal repeat segments
(1-4). Unit-length genomes are then encapsidated into
preassembled capsids. DNA-packaging is a complex biological process.
While it is commonly accepted that ATP hydrolysis is the driving force
behind it, the molecular mechanisms of DNA translocation and genome
packaging remain unclear. In general, the following five steps are
involved. (i) The recognition of concatemeric DNA by a specific protein
(complex) able to (ii) bind and cut the DNA at specific sequence motifs
(packaging signals, e.g. pac1 and
pac2), (iii) translocation of the DNA-protein complex into
the procapsid, (iv) packaging of one unit-length genome, and (v)
completion of the packaging process by cutting off excess DNA at the
portal region (5-7).
Recently, we have demonstrated that the HCMV pUL56 gene product
(pUL56), the homolog of the HSV-1 open reading frame UL28, is
associated with sequence-specific binding of DNA containing packaging
motifs leading to the suggestion that pUL56 plays a key role in DNA
packaging (7-9). Comparable results were reported of the HSV-1 pUL28,
demonstrating a direct interaction of pUL28 with DNA containing the
pac1 motif (10). Furthermore, by the use of viral mutants it
was demonstrated that the deletion of pUL28 leads to nuclear
accumulation of naked nucleocapsids and uncleaved concatemeric DNA (11,
12). In addition, it has been noted that the HCMV UL89 gene product,
the HSV-1 UL15 homolog, exhibits homology to the bacteriophage T4 gp17
terminase subunit, implying a similar function in DNA packaging (13).
However, this homology was only due to the ATP binding motifs. DNA
packaging of double-stranded DNA bacteriophage requires the terminase,
a complex of two proteins (14-16). Most bacteriophage terminases are hetero-oligomers with each subunit carrying a different function (17-20). The large subunit catalyzes the ATP-dependent
translocation of genomic DNA into the bacteriophage procapsids and the
small unit binds and cleaves concatenated DNA (21, 22). Mutations in
any of the encoding genes lead to an accumulation of empty procapsids
(proheads) and DNA concatemers (23). Rao et al. (24) demonstrated that the ATPase activity is associated with the large terminase subunit gp17 of bacteriophage T4.
Here we address the question which component of the HCMV terminase has
the ability to hydrolyze ATP. Exclusively, pUL56 exhibited an ATPase
activity, defining this protein as the central function in DNA
packaging of HCMV. Interestingly, we demonstrated that pUL89 and pUL56 interact.
Bacteria, Plasmid Construction, and
Oligonucleotides--
Escherichia coli strain BL21 codon
plus was used as the host strain for UL56- and UL89-carrying pGEX-5X-1
constructs. The UL89 cDNA was generated by reverse transcription
and PCR amplification. PCR primers amplified DNA segments from
Plasmid GST-UL56C was generated by digestion of pRC/CMV-UL56 (7) and
pGEX-5X-1 (Amersham Biosciences) as described previously (23).
The 1.5-kb fragment encoding the carboxyl-terminal half of HCMV pUL56
(amino acids 446-850) was ligated in-frame into pGEX-5X-1, yielding
pGEX-UL56C. For construction plasmid GST-UL89, plasmid pGEX-5X-1 was
digested with EcoRI and XhoI prior to insertion of a fragment encoding the entire HCMV pUL89. The respective fragment was obtained using plasmid pcDNA-UL89 as a template for PCR and the
following pair of synthetic oligonucleotides (restrictions sites are
underlined): 5'-CCGGAATTCATGTTGCGCGGAGACTCGGCC-3' (forward nucleotide) and 5'-CCGTCGAGCTAGCTGACCCTGAAACGGATG-3'
(reverse nucleotide).
Protein Purification--
A fresh overnight culture of E. coli BL21 carrying the plasmid pGEX-UL56C or pGEX-UL89 or
pGEX-5x-1 was diluted 1:100 in LB medium (1 liter) containing 50 µg/ml ampicillin and incubated at 37 °C. After the cells reached
an A600 of 0.5 the GST protein expression
was induced by addition of
isopropyl-1-thio- In Vitro Translation--
Plasmid pcDNA-UL89 (0.5 µg) and
plasmid pHM123 (0.5 µg), encoding HCMV IE1, was incubated with
[35S] methionine (10 mCi/ml) and 20 µl
TNTTMT7 Quick Master Mix (Promega, Madison, WI) in a final
volume of 30 µl for 1 h at 30 °C. Translation products were
analyzed by SDS-PAGE.
Antibodies--
HCMV pUL56-specific human polyclonal antibody
pabUL56 (7), which was purified from high titer human serum by column
affinity chromatography (Affi-Gel 10/15-pUL56). Affinity purification
of the anti-UL89 antibody was done as follows. The GST fusion protein, GST-UL89, was coupled to activated immunoaffinity supports Affi-Gel 10 and Affi-Gel 15 (1:2 Affi-Gel 10/Affi-Gel 15; Bio-Rad Laboratories) as
described by Bio-Rad, yielding Affi-Gel 10/15-pUL89. Unspecific binding
sites were blocked by incubation with buffer B (1 M
ethanolamine-HCl, pH 8.0, 0.02% NaN3) for 1 h. The
resin was equilibrated with start buffer (150 mM NaCl, 50 mM Tris-HCl, pH 8.0, 0.02% NaN3). High titer
human convalescent serum was incubated overnight with the prepared
affinity matrix. After the matrix was washed twice with 10 bed volume
of ice-cold start buffer, the bound antibody was eluted in 200 mM glycine-HCl, pH 2.5. The purified anti-pUL89 antibody,
pabUL89, was neutralized with 100 mM Tris-HCl, pH 8.0.
PAGE and Western Blot Analysis--
The fractions of the
purified GST fusion proteins were separated on 15% (w/v)
polyacrylamide gel, transferred to nitrocellulose sheets, and subjected
to Western blot analysis as described previously (7). The primary
antibodies used were pabUL56 antibody (1:10; 25) specific for pUL56 and
pabUL89 antibody (1:10) specific for pUL89.
Co-immunoprecipitation--
For immunoprecipitation
total cell extracts were prepared from HCMV-infected cultures 72 h
post infection by solubilization in co-immunoprecipitation
buffer (20 mM Tris-HCl, pH 7.5, 100 mM NaCl,
0.5% Nonidet P-40, 5 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride, 100 units/ml Trasylol) and ultrasonic
treatment. Insoluble material was sedimented for 10 min at 10,000 × g. Comparable amounts of extracts and pabUL89 (1:20),
were incubated for 2 h at 4 °C. Protein A-Sepharose was added,
and the reaction mixture was incubated for another 2 h at 4 °C.
The probes were washed in co-immunoprecipitation buffer, incubated at
95 °C for 3 min, and subjected to SDS-PAGE.
In Vitro Binding Assay--
The fusion protein pGEX-UL56C was
expressed in E. coli strain BL21, and protein purification
was carried out according to the instructions of the manufacturer
(Amersham Biosciences). Equal amounts of GST-UL56C fusion protein or
GST alone loaded on glutathione-Sepharose 4B (Amersham Biosciences)
were incubated with in vitro translated pUL89 or the
immediate-early protein 1 (IE1) 2 h at 4 °C in 500 µl of
binding buffer (0.05% (v/v) Nonidet P-40, 50 mM Hepes, pH 7.3, 10% (v/v) glycerol, 0.1% (w/v) bovine serum albumin, 300 mM NaCl). Samples were washed with binding buffer and
subsequently subjected to SDS-PAGE, fixation and autoradiography.
Radioactive signals were quantitatively analyzed using a BioImager
(Fuji, Raytest, Straubenhardt, Germany) with the program AIDA.
ATPase Activity--
Purified GST fusion proteins GST-UL89,
GST-UL56C, or the control proteins GST (each 1.2 µg) and
Apyrase were incubated with 1 µCi of
[ Purification of GST-UL56 C and GST-UL89--
For this purpose
E. coli BL21 cells expressing GST-UL89 or GST-UL56C fusion
proteins were harvested and purified by GSTrapTM column
chromatography. Aliquots of every fraction were assayed for protein
content by SDS-PAGE followed by Coomassie staining (Fig.
1, A and C) or
transfer to nitrocellulose. The nitrocellulose filters were reacted
with the affinity purified antibodies against pUL56 and pabUL56, (Fig.
1B) or against pUL89 and pabUL89, (Fig. 1D).
Fraction 2 containing GST-UL56C (Fig. 1, A and B)
or GST-UL89 (Fig. 1, C and D), respectively, was
used for further analysis.
ATPase Activity of GST-UL56C--
To identify the terminase
subunit that has the ability to hydrolyze [ Analysis of the ATP Cleavage Site--
To characterize the
position of the enzymatic cleavage site, experiments were performed
with [ Kinetic of the ATPase Activity--
To further investigate ATP
hydrolysis, the time course of the reaction was analyzed. The ATPase
activity of GST-UL56C was already observed after 10 min of incubation
(Fig. 4B, lane 5). In contrast GST-UL89 needed an incubation time of 60 min (Fig. 4A, lane 8). The control GST protein did not show
an increase of ATPase activity over time (Fig. 4C).
Hydrolysis of radiolabeled ATP into ADP and Pi was measured
by incubation with Apyrase (Fig. 4, lane 2). The
buffer control is shown in lane 1. These experiments support
the notion that the terminase subunit pUL56 is the main ATPase.
Saturation of the ATPase Activity--
To determine whether the
enzymatic reaction could be saturated, experiments were performed with
increasing protein amounts. ATP hydrolysis was verified by incubation
with Apyrase (Fig. 5, lane 1). Interestingly, a concentration of GST-UL56C of 0.6 µg/ml was defined as the point where the reaction is in the log
phase. This amount of protein converted 65% of ATP into Pi
(Fig. 5B, lane 4). In contrast GST-UL89 still
showed almost no enzymatic activity (Fig. 5A). GST as well
as buffer were used as control reactions (Fig. 5C,
Fig. 5, A-C, lane 1). Our results demonstrated that the hydrolysis of ATP is saturated at a concentration of about 0.6 µg/ml GST-UL56C.
Influence of GST-UL89 on the GST-UL56 ATPase Activity--
To
further investigate whether GST-UL89 could enhance the ATPase activity
of GST-UL56C, experiments under limiting concentrations of GST-UL56C
(0.3 µg/ml) were performed. GST-UL89 (0.6 and 3.0 µg/ml) was added
to the ATPase reaction mix of UL56 (0.6 µg/ml) and incubated for
1 h. In the presence of GST-UL89, the UL56 enzymatic activity was
stimulated up to 30% (Fig. 6, lane
3-4) while acetylated bovine serum albumin had no influence (Fig.
6, lane 5). Apyrase was used for verification of
the position of Pi (Fig. 6, lane 2) GST as well
as the buffer was used as control reactions (Fig. 6, lane
7, lane 1). Thus pUL89 stimulates pUL56 ATPase
activity.
Interaction of the Terminase Subunits pUL56 and
pUL89--
GST pull down assays were carried out using the
carboxyl-terminal half of pUL56. To this end, the GST-UL56C containing
the carboxyl-terminal portion or GST itself were immobilized on
glutathione-Sepharose beads and incubated either with in
vitro translated [35S]methionine-labeled pUL89
(in vitro UL89; Fig. 7:
lane 3) or [35S]methionine-labeled IE1
(in vitro IE1; Fig. 7, lane 6). The amount of
bound material was analyzed by SDS-PAGE and autoradiography. As shown
in Fig. 7, pUL89 interacted specifically with GST-UL56C (lane
3) but not with GST alone (lane 1). In vitro
translated IE1, used as a negative control, did not interact with
GST-UL56C (Fig. 2, lane 5). To estimate the intensity of the
pUL56-pUL89 interaction, quantification was performed using bioimaging
analysis of the fluorographs. Binding of pUL89 to GST-pUL56C was 25×
stronger than that of GST alone to pUL89. These experiments
demonstrated for the first time a direct interaction of pUL89 with
pUL56.
To further investigate a direct interaction between both proteins
co-immunoprecipitation prior to Western blot analysis was performed.
For co-immunoprecipitation the antibody pabUL89 was used. The following
Western blot analysis using pabUL56 detected pUL56 as the full size
protein of 130 kDa in HCMV-infected cell extracts and
co-immunoprecipitates (Fig. 8,
lanes 3 and 4). No detection was observed in
mock-infected cell extracts or co-immunoprecipitates (Fig.
8A, lanes 1 and 2).
Co-immunoprecipitation with an antibody against HCMV pUL112/113, mab
M23, was used as a control. The resulting co-immunoprecipitates were
not detected by pabUL56 (Fig. 8B, lanes 3 and
4). The protein recognized by the antibody pabUL89 was
demonstrated in Western blots of mock- and HCMV-infected cell extracts
(Fig. 8, C and D). In HCMV-infected cell extracts
the 75-kDa pUL89 was detected. These experiments implicates a direct
interaction between HCMV pUL56 and pUL89.
Terminase subunits are the only proteins known to be involved in
packaging of viral DNA and have, so far, been described for double-stranded DNA bacteriophages only (2, 14, 26, 27). These enzymes
are normally hetero-oligomeric complexes with multiple functions
(17-20). Although the exact mechanism of DNA translocation is not
known, it is commonly accepted that this process is
energy-dependent. Studies by Guo et al.
(26) and Shibata et al. (3) demonstrated that
hydrolysis of one ATP provides energy to translocate two base pairs
under in vitro conditions.
It has been noted that the HCMV UL89 gene product, the homolog of
herpesvirus simplex type-1 (HSV-1) pUL15, exhibits homology to the
bacteriophage T4 gp17 terminase subunit (13). Therefore we investigated
whether either or both HCMV proteins exhibited an ATPase activity.
Interestingly, the ATPase activity was only associated with pUL56,
which hydrolyzed the ATP hydrolyzing enzymes contain a Walker box: box A, GKT; box B, DE).
Both regions are found in pUL89 and its homologs. Therefore the
presumption was that pUL89 would have an ATPase activity. However,
under the conditions we used pUL89 did not have an enzymatic activity.
A motif in pUL56 that could theoretically constitutes a partial Walker
box A is GKQ (amino acids 714-716). Recently it was
demonstrated that a mutation from GKT to AKT in HSV-1 UL15, the homolog
of pUL89, was unable to complement a UL15 mutant virus (29), thus
leading to the presumption that ATPase activity is important for
herpesvirus maturation. Based on our observations we postulate that the
energy for translocation of the concatemeric DNA to the preformed
procapsids is provided by the pUL56-mediated ATP hydrolysis. Recently,
a new class of anti HCMV agents (30), benzimidazole ribonucleosides,
were shown to inhibit HCMV DNA maturation via interaction with the
viral UL89 (31) and UL56 (32) gene products. In addition, analysis of
mutants of pUL56 homologs of HSV-1, pUL28, and pseudorabies virus
demonstrated that the deletion of the protein leads to nuclear
accumulation of naked nucleocapsids and concatemeric DNA (10, 11, 33). However, nothing was known to date about the function of pUL56. Our
findings could now give an explanation for the prevention of packaging
after deletion of the gene in pseudorabies virus and HSV-1. Protein
deletion will lead to the loss of energy for translocation of the
concatemers to the procapsids. In consequence the next step of
packaging into the capsid and cleavage into unit-length genomes will
not occur. This resulted in the accumulation of concatemeric DNA and
naked capsids in the nucleus.
Together with our former study (8) we suggest that pUL56 (i) mediates
the specific binding to pac sequences on the concatemers and
(ii) provides energy for the translocation of the DNA into the
procapsids. The role of the terminase subunit pUL89 during packaging of
unit-length genome remains to be determined.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
17 to
+2306 bp of the HCMV (strain AD169) UL89 open reading frame sequence
except that a single nucleotide 5' of the initiation codon was deleted
to generate an NdeI site. This fragment was cloned into the
pCRII vector (Invitrogen, Karlsruhe, Germany) to generate construct pUB8. A BamHI-to-XbaI fragment from pUB8 was
cloned into the corresponding sites of the vector pcDNA3.1/His C
(Invitrogen) to generate pcDNA-UL89.
-D-galactopyranoside to a final
concentration of 0.1 mM and incubated for 2 h at
37 °C. Sedimented cells were lysed in 40 ml of binding buffer (20 mM sodium phosphate, 0.15 M NaCl, pH 7.4)
containing 250 µl of 1 M MgCl2, 25 µl of 1 M MnCl, 40 µl of DNase I (10 mg/ml), and 400 µl of
lysozyme (10 mg/ml) incubated on ice for 30 min and sonicated on ice.
Undissolved material was sedimented at 5000 × g at
4 °C and passed through a 0.2-µm filter. The purification was
performed with a 1-ml GSTrapTM column by using a
ÄKTATM Prime machine (Amersham Biosciences) according
to the instruction of the manufacturer. The column was washed with
three bed volumes binding buffer prior to loading the proteins. Elution
was performed with 10 bed volumes elution buffer (50 mM
Tris-HCl, 10 mM glutathione, pH 8.0), and ten fractions
were collected. The fractions were analyzed by SDS-PAGE. Fractions
containing the proteins were stored at
80 °C.
-33P]ATP (specific activity 2500 Ci/mmol),
[
-32P]ATP (specific activity 3000 Ci/mmol),
[
-32P]dATP (specific activity 3000 Ci/mmol), or
[
-32P]GTP (specific activity 3000 Ci/mmol) in 30 µl
of nuclease buffer. The samples were incubated at 37 °C for 1 h. The reaction was terminated by adding EDTA up to a final
concentration of 50 mM. A 1-µl aliquot of the reaction
mixture was applied onto a 20-cm-long PEI-F cellulose strip
(Merck Eurolab, Darmstadt, Germany) and dried. The chromatogram was
developed in 1 M formic acid and 0.5 M LiCl
according to Guo et al. (26). The run was stopped
when the solvent front reached 1 cm from the upper edge, dried, and autoradiographed on Kodak BIOMAX MR. Radioactive signals were quantified using a BioImager and AIDA software (Raytest). The values of
produced Pi were calculated by subtracting the GST-only value from each GST fusion protein value. Nonradioactive nucleotides were used as standards. The spots were visualized under UV light and
marked on the cellulose.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (29K):
[in a new window]
Fig. 1.
Purification of GST fusion proteins.
Aliquots of E. coli BL21-expressing (A) GST-UL56C
or (C) GST-UL89 as well as the fraction after affinity
chromatography were subjected to SDS-PAGE prior to Coomassie staining.
Aliquots of the same fractions were separated by SDS-PAGE followed by
Western blot with the specific pabUL56 antibody (B) against
pUL56 or pabUL89 (D) against pUL89. Molecular mass
standards (M) are indicated on the left; position
of UL89 and UL56 is indicated by an arrow.
-33P]ATP,
experiments with purified GST fusion proteins were performed. Hydrolysis of radiolabeled ATP of purified terminase subunits was
assayed following chromatographic separation of ATP and ADP + Pi on PEI-F cellulose. Addition of GST-UL56C to the
reaction mixture resulted in generation of 33Pi
(Fig. 2B, lane 5)
comparable with the reaction with the Apyrase, an ATPase and
ADPase from Solanum tuberosum (EC 3.6.1.5; Fig. 2B, lane 2). GST-UL89 did not show a high
hydrolysis of ATP (Fig. 2B, lane 4). GST alone
did not show a significant ATP hydrolysis (Fig. 2B,
lane 3). These experiments lead to the suggestion that hydrolysis of ATP is mainly associated with the terminase subunit pUL56.

View larger version (16K):
[in a new window]
Fig. 2.
ATPase analysis of purified GST-UL89 and
GST-UL56C. [
-33P]ATP (1 µCi) was used as the
substrate. Lane 1, buffer control; lane
2, 5 units of Apyrase; lane 3, GST-UL89;
lane 4, GST-UL56C; lane 5, GST alone. The
position of ATP, ADP, and Pi are indicated by
arrows.
-32P]ATP, [
-32P]dATP, or
[
-32P]GTP. The reaction with GST-UL56C yielded a more
slowly migrating radiolabeled product corresponding to ADP (Fig.
3A, GST-UL56C), which results from the hydrolysis of the
-
phosphodiester bond. After the incubation with Apyrase, AMP was still detectable
because this enzyme has also an ADPase activity (Fig. 3A,
Apyrase). The buffer control (Fig. 3A,
buffer) as well as the reaction with GST (Fig.
3A, GST) or GST-UL89 (Fig. 3A,
GST-UL89) did not show a specific reaction. Experiments with
dATP demonstrated that GST-UL56C could hydrolyze dATP (Fig.
3B, GST-UL56C), but the amount of converted dATP
was reduced up to 7-fold. The reaction was specific for ATP since GTP
was not hydrolyzed (Fig. 3C, GST-UL56C). These
results demonstrated that GST-UL56C hydrolyzes the
-
phosphodiester bond of ATP, generating ADP and Pi.

View larger version (23K):
[in a new window]
Fig. 3.
Determination of the cleavage site during ATP
hydrolysis. In this experiment 1 µCi of
[
-32P]ATP, [
-32P]dATP or
[
-32P]GTP was used as substrate. The reaction was
terminated by adding 50 mM EDTA. A, lane
1, buffer control; lane 2, 5 units of
Apyrase; lane 3, GST-UL89 (1.25 µg); lane
4, GST-UL56C (1.25 µg); lane 5, GST (1.25 µg).
B, lane 1, buffer control; lane 2, 5 units of Apyrase; lane 3, GST-UL89; lane
4, GST-UL56C; lane 5, GST. C, lane
1, buffer control; lane 2, 5 units of
Apyrase; lane 3, GST-UL89; lane 4,
GST; lane 5, GST-UL56. The position of ATP, ADP, and
Pi are indicated by arrows. The amount of
hydrolyzed Pi is shown on the bottom.

View larger version (17K):
[in a new window]
Fig. 4.
Time course of ATP hydrolysis.
[
-33P]ATP (1 µCi) was used as substrate. The
reaction was terminated by addition of EDTA of 50 mM.
GST-UL89 (A), GST-UL56C (B), and GST
(C). Lane 1, buffer control; lane 2,
Apyrase; lane 3, GST alone; lane 4, 0 min of incubation; lane 5, 10, 20, 30, and 60 min of
incubation. The amount of hydrolyzed Pi is shown on the
bottom.

View larger version (18K):
[in a new window]
Fig. 5.
Saturation of ATP hydrolysis. 1 µCi of
[
-33P]ATP was used as the substrate. Analysis of
GST-UL89 (A), GST-UL56C (B), and GST
(C). Lane 1, buffer control; lane 2,
Apyrase; lane 3, 0.15, 0.30, 0.60, 1.20, and 3.00 µg of protein. The amount of hydrolyzed Pi is shown on
the bottom.

View larger version (21K):
[in a new window]
Fig. 6.
Influence of GST-UL89 on the GST-UL56C ATPase
activity. [
-33P]ATP (1 µCi) was used as the
substrate. Lane 1, buffer control; lane 2,
Apyrase; lane 3 GST-UL56C (0.6 µg); lane
4, GST-UL56C (0.6 µg) and GST-UL89 (0.6 µg); lane
5, GST-UL56C (0.6 µg) and GST-UL89 (3.0 µg); lane
6, GST-UL56C (0.6 µg) and BSA (3.0 µg); lane 7, GST
(0.6 µg); lane 8, GST-UL89 (0.6 µg); and lane
9, GST-UL56C (0.6 µg). The amount of hydrolyzed Pi
is shown on the bottom.

View larger version (13K):
[in a new window]
Fig. 7.
Binding of pUL89 to an immobilized
carboxyl-terminal portion of pUL56. Glutathione-Sepharose 4B beads
loaded with GST or GST-UL56C were incubated with in vitro
translated UL89 (in vitro UL89) or IE1 (in vitro
IE1). The bound material was subjected to SDS-PAGE prior to
autoradiography. The arrows indicated the position of pUL89
and IE1, and the molecular mass markers (M) are
indicated on the left. Specifically the immobilized
radioactivity was quantified using bioimaging analysis. The relative
amounts of bound radioactivity are indicated by % values.

View larger version (8K):
[in a new window]
Fig. 8.
Interaction of the terminase subunits.
Mock-infected or HCMV-infected at 72 h post infection were
co-immunoprecipitated with pabUL89 and subjected to SDS-PAGE prior to
transfer onto nitrocellulose. Immunoblot analysis were performed using
pabUL56. The arrows indicate the position of pUL56. The
molecular mass markers (M) are indicated on the
left.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-
phosphodiester bond, generating ADP and
Pi. Other nucleosides were not hydrolyzed by pUL56.
Preincubation of the recombinant protein with the specific antibody
could reduce the enzymatic activity to ~50%, while unspecific antibodies had almost no effect (data not shown). Although pUL89 did
not have an obvious enzymatic activity, it enhanced the
pUL56-associated ATPase activity by about 30%. Comparable observations
were reported by Leffers and Rao (28) with the bacteriophage T4
terminase subunits. The large subunit gp17 exhibited an ATPase activity and that the gp17 activity was enhanced by gp16. This bacteriophage terminase subunit has two ATP-binding sites in the central and a
metal-binding motif in the C-terminal portion of the protein (28). A
mutation of either the metal-binding motif or the ATP-binding site
resulted in the loss of gp17 function (22). Furthermore we showed that
both proteins interact under in vitro conditions as well as
in infected cells. This could be an explanation for the enhancing of
the pUL56-associated ATPase activity by pUL89. Therefore, it is
possible that HCMV pUL56 and pUL89 are the functional homologues to the
T4 gp16 and gp17 subunits, respectively.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Thomas Stamminger and Helmut Fickenscher for critical reading the manuscript, Mark Underwood (GlaxoWellcome) for kindly providing the plasmid pUB8, and Thomas Stamminger for providing the plasmid pHM128 expressing HCMV IE1. E. B. thanks B. Fleckenstein for kind support.
| |
FOOTNOTES |
|---|
* This study was supported by the Johannes and Frieda Marohn Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Recipient of a Habilitationstipendium from the Deutsche
Forschungsgemeinschaft. To whom correspondence should be addressed: Institut für Klinische und Molekulare Virologie, Schlossgarten 4, 91054 Erlangen, Germany. Tel.: 49-9131-8522104; Fax: 49-9131-8526493; E-mail: eebogner@viro.med.uni-erlangen.de.
Published, JBC Papers in Press, December 13, 2001, DOI 10.1074/jbc.M108984200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: HCMV, human cytomegalovirus; HSV, herpesvirus simplex.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Chou, J., and Roizman, B. (1985) Cell 41, 803-811[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Deiss, L. P.,
Chou, J.,
and Frenkel, N.
(1986)
J. Virol.
59,
605-618 |
| 3. | Shibata, H., Fujisawa, H., and Minagawa, T. (1987) J. Mol. Biol. 196, 845-851[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Spaete, R. R.,
and Mocarski, E. S.
(1985)
J. Virol.
54,
817-824 |
| 5. | Higgins, R. R., and Becker, A. (1994) EMBO J. 13, 6152-6161[Medline] [Order article via Infotrieve] |
| 6. |
Smith, M. P.,
and Feiss, M.
(1993)
J. Bacteriol.
175,
2393-2399 |
| 7. | Bogner, E., Reschke, M., Reis, B., Mockenhaupt, T., and Radsak, K. (1993) Virology 196, 290-293[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Bogner, E.,
Radsak, K.,
and Stinski, M. F.
(1998)
J. Virol.
72,
2259-2264 |
| 9. | Bogner, E. (1999) Gene Ther. Mol. Biol. 3, 75-78 |
| 10. |
Adelman, K.,
Salmon, B.,
and Baines, J. D.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
3086-3091 |
| 11. |
Addison, C.,
Ricon, F. J.,
and Preston, V. G.
(1990)
J. Gen. Virol.
71,
2377-2384 |
| 12. |
Tengelsen, L. A.,
Pederson, N. E.,
Shaver, P. R.,
Wathen, M. W.,
and Homa, F. L.
(1993)
J. Virol.
67,
3470-3480 |
| 13. | Davison, A. J. (1992) Virology 186, 9-14[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Black, L. W. (1988) The Bacteriophages , pp. 321-323, Plenum Publishing Corp., New York |
| 15. | Bhattacharyya, S. P., and Rao, V. B. (1993) Virology 196, 34-44[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Feiss, M., and Becker, A. (1983) DNA Packaging and Cutting, Lambda II , pp. 305-330, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 17. | Black, L. W., Showe, M. K., and Steven, A. C. (1994) Molecular Biology of Bacteriophage T4 , pp. 218-255, American Society for Microbiology, Washington, D. C. |
| 18. | Casjens, S., and Hendrix, R. (1988) The Bacteriophages , Vol. 1 , pp. 15-92, Plenum Publishing Corp., New York |
| 19. | Eppler, K., Wyckoff, E., Goates, J., Parr, R., and Casjens, S. (1991) Virology 183, 519-538[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Fujisawa, H., and Hearin, P. (1994) Semin. Virol. 5, 5-13 |
| 21. | Bhattacharyya, S. P., and Rao, V. B. (1994) Gene 146, 67-72[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Kuebler, D., and Rao, V. B. (1998) J. Mol. Biol. 281, 803-814[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Black, L. W. (1995) BioEssays 17, 1025-1030[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Rao, V. B., Leffers, G., and Kuebler, D. (1996) The 11th Evergrenn International Bacteriophage T4 Meeting , Olympia, WAAugust, 1996 |
| 25. |
Giesen, K.,
Radsak, K.,
and Bogner, E.
(2000)
J. Gen. Virol.
81,
2231-2244 |
| 26. | Guo, P., Peterson, C., and Anderson, D. (1987) J. Mol. Biol. 197, 229-236[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Powell, D.,
Franklin, J.,
Arisaka, F.,
and Mosig, G.
(1990)
Nucleic Acids Res.
18,
4005 |
| 28. | Leffers, G., and Rao, V. B. (2000) J. Bio. Chem. 276, 37127-37136 |
| 29. | Yu, D., and Weller, S. K. (1998) Virology 243, 32-44[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Townsend, L. B., Devivar, R. V., Turk, S. R., Nassiri, M. R., and Drach, J. C. (1995) J. Med. Chem. 38, 4098-4150[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Underwood, M. R.,
Harvey, R. J.,
Stanat, S. C.,
Hemphill, M. L.,
Miller, T.,
Drach, J. C.,
Townsend, L. B.,
and Biron, K. K.
(1998)
J. Virol.
72,
717-772 |
| 32. |
Krosky, P. M.,
Underwood, M. R.,
Turk, S. R.,
Feng, K. W-H.,
Jain, R. K.,
Ptak, R. G.,
Westerman, A. C.,
Biron, K. K.,
Townsend, L. B.,
and Drach, J. C.
(1998)
J. Virol.
72,
4721-4728 |
| 33. |
Mettenleiter, T. C.,
Saalmüller, A.,
and Weiland, F.
(1993)
J. Virol.
67,
1236-1245 |
This article has been cited by other articles:
![]() |
E. M. Borst, K. Wagner, A. Binz, B. Sodeik, and M. Messerle The Essential Human Cytomegalovirus Gene UL52 Is Required for Cleavage-Packaging of the Viral Genome J. Virol., March 1, 2008; 82(5): 2065 - 2078. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. McVoy and D. E. Nixon Impact of 2-Bromo-5,6-Dichloro-1-{beta}-D-Ribofuranosyl Benzimidazole Riboside and Inhibitors of DNA, RNA, and Protein Synthesis on Human Cytomegalovirus Genome Maturation J. Virol., September 1, 2005; 79(17): 11115 - 11127. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Xiao, W.-D. Moll, S. Guo, and P. Guo Binding of pRNA to the N-terminal 14 amino acids of connector protein of bacteriophage phi29 Nucleic Acids Res., May 10, 2005; 33(8): 2640 - 2649. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Adamo, J. Schroer, and T. Shenk Human Cytomegalovirus TRS1 Protein Is Required for Efficient Assembly of DNA-Containing Capsids J. Virol., October 1, 2004; 78(19): 10221 - 10229. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Underwood, R. G. Ferris, D. W. Selleseth, M. G. Davis, J. C. Drach, L. B. Townsend, K. K. Biron, and F. L. Boyd Mechanism of Action of the Ribopyranoside Benzimidazole GW275175X against Human Cytomegalovirus Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1647 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Nixon and M. A. McVoy Dramatic Effects of 2-Bromo-5,6-Dichloro-1-{beta}-D-Ribofuranosyl Benzimidazole Riboside on the Genome Structure, Packaging, and Egress of Guinea Pig Cytomegalovirus J. Virol., February 15, 2004; 78(4): 1623 - 1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Williams, C. B. Hartline, N. L. Kushner, E. A. Harden, D. J. Bidanset, J. C. Drach, L. B. Townsend, M. R. Underwood, K. K. Biron, and E. R. Kern In Vitro Activities of Benzimidazole D- and L-Ribonucleosides against Herpesviruses Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2186 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. White, N. D. Stow, A. H. Patel, M. Hughes, and V. G. Preston Herpes Simplex Virus Type 1 Portal Protein UL6 Interacts with the Putative Terminase Subunits UL15 and UL28 J. Virol., June 1, 2003; 77(11): 6351 - 6358. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Scholz, S. Rechter, J. C. Drach, L. B. Townsend, and E. Bogner Identification of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus Nucleic Acids Res., March 1, 2003; 31(5): 1426 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Scheffczik, C. G. W. Savva, A. Holzenburg, L. Kolesnikova, and E. Bogner The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure Nucleic Acids Res., April 1, 2002; 30(7): 1695 - 1703. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |